01 / Founder · biology · Cairo / Boston / Munich
Making antibodies
speak to immunity.
I’m Mahmoud Eljendy, co-founder and CEO of Proteinea.
We build the biology and computational methods to engineer how antibodies instruct the immune system.
A little more about meThe work, in brief
The next generation of therapeutics will not just bind. They will give the immune system better instructions.
See the workRecently